DM
ALNA

Deerfield Management’s Allena Pharmaceuticals ALNA Stock Holding History

Deerfield Management’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-605,100
Closed -$6.09M – 129
2017
Q4 		$6.09M Buy
+605,100
New +$7.46M 0.24% 81

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PIM
Partner Investment Management San Francisco, California $13.9M AUM 55.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Deerfield Management's ALNA Position: Q1 2018 in Review

Deerfield Management sold out of Allena Pharmaceuticals (ALNA) in Q1 2018, closing a stake of 605,100 shares — an estimated $6.09M sold.

Deerfield Management first reported a position in ALNA in Q4 2017 and held it in 1 quarter. The position peaked at $6.09M in Q4 2017. 42 funds tracked by Wall St. Rank hold ALNA as of Q1 2018.

  • Deerfield Management reported no remaining Allena Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Deerfield Management sold 605,100 Allena Pharmaceuticals shares in Q1 2018, an estimated $6.09M.
  • Deerfield Management first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 1 quarter.
  • Deerfield Management's Allena Pharmaceuticals position peaked at $6.09M in Q4 2017.
  • 42 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q1 2018.

Based on Deerfield Management's 13F filing for Q1 2018, filed 15 May 2018.